Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum

Annals of Tropical Medicine and Parasitology

Volumn 90, Issue 3, 1996, Pages 295-302

  Buffet, P A ^a   Garin, Y J F ^a   Sulahian, A ^a   Nassar, N ^a   Derouin, F ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; MEGLUMINE; PAROMOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA INFANTUM; LIVER; LUNG; MOUSE; NONHUMAN; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; TARGET ORGAN; VISCERAL LEISHMANIASIS;

EID: 0029970079     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1996.11813054     Document Type: Article

References (20)

1. AEBISCHER, T. (1994). Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitology Today, 10, 25-28.
2. ALVAR, J. (1994). Leishmaniasis and AIDS coinfection: the Spanish example. Parasitology Today, 10, 160-163.
3. BERMAN, J. D., HANSON. W. L., CHAPMAN, W. L., ALVING, C. R. & LOPEZ-BERESTEIN, G. (1986). Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrobial Agents and Chemotherapy, 30, 847-851.
4. BERMAN, J. D., KSIONSKI, G., CHAPMAN, W. L., WAITS, V. B. & HANSON, W. L. (1992). Activity of amphotericin B cholesterol dispersion (Amphocil®) in experimental visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 36, 1978-1980.
5. BLACKWELL, J. M., ROBERTS, B. & ALEXANDER, J. (1985). Response of BALB/c mice to leishmanial infection. Current Topics in Microbiology and Immunology, 122, 97-106.
6. BRYCESON, A. (1987). Therapy in man. In The Leishmaniases in Biology and Medicine, eds Peters, W. & Killick-Kendrick, R. pp. 847-907. London: Academic Press.
7. BUFFET, P. A., SULAHIAN, A., GARIN, Y. J. F., NASSAR, N. & DEROUIN, F. (1995). Culture titration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrobial Agents and Chemotherapy, in press.
8. CARTER, K. C., BAILLIE, A. J. & ALEXANDER, J. (1993). Genetic control of drug-induced recovery from murine visceral leishmaniasis. Journal of Pharmacy and Pharmacology, 45, 795-798.
9. CARTER, K. C., BAILLIE, A. J., ALEXANDER, J. & DOLAN, T. F. (1988). The therapeutic effect of sodium stiboglucanate in Balb/c mice infected with Leishmania donovani is organ-dependent. Journal of Pharmacy and Pharmacology, 40, 370-373.
10. CHUNGE, C. N., OWATE, J., PAMBA, H. O. & DONNO, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or in combination with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 221-225.
11. CROFT, S. L., DAVIDSON, R. N. & THORNTON, E. A. (1991). Liposomal amphotericin B in the treatment of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy, 28, 111-118.
12. GRAMICCIA, M., GRADONI, L. & ORSINI, S. (1992). Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Annals of Tropical Medicine and Parasitology, 86, 613-620.
13. HERWALDT, B. T. & HERMAN, J. D. (1992). Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam®) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene, 46, 296-306.
14. JANKNEGT, R., DE MARIE, S., BAKKER-WOUDENBERG, I. A. J. M. & CROMMELIN, D. J. A. (1992). Liposomal and lipid formulations of Amphotericin B. Clinical Pharmacokinetics, 23, 279-291.
15. MISHRA, M., BISWAS, U. K., JHA, D. N. & KHAN, A. B. (1992). Amphotericin B versus pentamidine in antimony-unresponsive kala-azar. Lancet, ii, 1256-1257.
16. MISHRA, M., BISWAS, U. K., JHA, D. N. & KHAN, A. B. (1994). Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet, ii, 1599-1600.
17. NEAL, R. (1987). Experimental chemotherapy. In The Leishmaniases in Biology and Medicine, eds Peters, W. & Killick-Kendrick, R. pp. 793-845. London: Academic Press.
18. REES, P. H. & KAGER, P. A. (1987). Visceral leishmaniasis and post-kala-azar dermal leishmaniasis. In The Leishmaniases in Biology and Medicine, eds Peters, W. & Killick-Kendrick, R. pp. 583-615. London: Academic Press.
19. SEAMAN, J., PRYCE, D., SONDORP, H. E., MOODY, A., BRYCESON, A. D. M. & DAVIDSON, R. N. (1993) Epidemic visceral leishmaniasis in the Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. Journal of Infectious Diseases, 168, 715-720.
20. TROTTER, E. R., PETERS, W. & ROBINSON, B. L. (1980). The experimental chemotherapy of leishmaniasis. IV. The development of a rodent model for visceral infection. Annals of Tropical Medicine and Parasitology, 74, 128-138.